Cost-Effectiveness Analysis of Biological Disease-Modifying Antirheumatic Drugs in the Treatment of Russian Patients with Rheumatoid Arthritis Who Failed Previous Anti-Tnf-Alfa Therapy
Nov 1, 2013, 00:00 AM
10.1016/j.jval.2013.08.1489
https://www.valueinhealthjournal.com/article/S1098-3015(13)03394-9/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1328
First Page :
A562
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)03394-9&doi=10.1016/j.jval.2013.08.1489